Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc
Journal website

Case Report

Volume 5, Number 3, September 2016, pages 92-96

Combined Surgery for Uterine and Renal Cell Cancers in Obese Patients: A Case Series


Figure 1.
Figure 1. A preoperative CT scan of the abdomen reveals an enlarged, irregular uterus with multiple calcifications as well as an exophytic, heterogeneous mass extending from the inferior pole of the right kidney.


Table 1. Review of Cases With Synchronous Uterine and Renal Tumors, Patient Characteristics, Surgical Management, and Pathology
CaseAgeaBMI (kg/m2)SurgeryUterine pathologyRenal pathology
aAge at diagnosis. bEndometrioid histology unless otherwise specified. cStaging assigned by the joint 2010 version of the International Federation of Gynecology and Obstetrics (FIGO)/Tumor, Nodes, Metastasis (TNM) classification system for uterine carcinoma. dStaging assigned by the 2010 version of the tumor, nodes, metastasis (TNM) classification system for kidney cancer. BMI: body mass index; RaTLH: robotic-assisted total laparoscopic hysterectomy; BSO: bilateral salpingo-oophorectomy; TAH: total abdominal hysterectomy; PPLND: pelvic and para-aortic lymph node dissection.
15361RaTLH, BSO + hand-assisted laparoscopic R radical nephrectomyG1IIClear cell, grade 3T2aNX
27149TAH, BSO, PPLND + open R radical nephrectomyG1IAClear cell, grade 2T2aN0
37432TAH, BSO, omentectomy, splenectomy + open L nephrectomy, adrenalectomyCarcinosarcomaIVBPapillary, type II, grade 3T2aNX
47139TAH, BSO, PPLND, omentectomy, splenectomy + open L radical nephrectomy, adrenalectomyPapillary serous carcinomaIVBPapillary, type II, grade 3T1aN0
57038TAH, BSO, PPLND, omentectomy + open L partial nephrectomyCarcinosarcomaIAClear cell, grade 2T1aN0
64645TAH, BSO, PPLND + open R nephrectomyG1IAClear cell, grade 2T1bN0


Table 2. Review of Cases With Synchronous Uterine and Renal Tumors, Perioperative Outcomes and Disease Status
CaseOperative time, minEBL, mLBlood productsaLength of hospitalization, daysOperative complicationDisease status
aTotal blood products transfused during hospitalization. EBL: estimated blood loss; NED: no evidence of disease; PRBCs: packed red blood cells; FFP: fresh frozen plasma; PCC: prothrombin complex concentrate.
1412200None7NoneNED 32 months from diagnosis
23081,00027 units PRBCs, 17 units FFP, 9 units platelets, 5 units cryoprecipitate, 1 unit PCC4Postoperative bleeding, liver lacerationN/A; died on postoperative day 3
32912,0004 units PRBCs5Cystotomy, splenectomyDeceased, presumptively from uterine carcinosarcoma, approx. 4 months from diagnosis
42972,2753 units PRBCs6SplenectomyAlive with recurrent endometrial cancer with intracranial metastatic disease; recently completed palliative whole brain radiation
53791,0001 unit PRBCs6NoneNED 19 months from diagnosis
62362,6005 units PRBCs8NoneRecords unavailable